Genomic characterisation of Crimean-Congo haemorrhagic fever virus (CCHFV) in Tajikistan identifies a novel reassortant virus
PLOS Neglected Tropical Diseases · 07.04.2026 · 20 (4) · e0014204
DOI: 10.1371/journal.pntd.0014204 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Neglected Tropical Diseases, online erschienen am 07.04.2026. Verfasst von Jake D'Addiego und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infection Biology, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, United Kingdom. Hauptthemen laut MEDLINE: Hemorrhagic Fever Virus, Crimean-Congo, Genome, Viral, Reassortant Viruses, Hemorrhagic Fever, Crimean. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC0). Gefördert von: NIAID NIH HHS, Biotechnology and Biological Sciences Research Council, National Institute of Allergy and Infectious Diseases.
Abstract (Originalsprache)
Crimean-Congo haemorrhagic fever virus (CCHFV) is an important human tick-borne pathogen, able to cause severe haemorrhagic fever. CCHFV is endemic in Tajikistan, which records between 5–38 cases of CCHF a year from southern regions. Molecular surveillance of CCHFV is crucial to implement effective prevention and control strategies, understand viral evolution, study transmission dynamics, and develop effective diagnostics, therapeutics, and vaccines. While the presence of Asia-1 and Asia-2 genotypes has been previously reported, only two historical samples from Tajikistan have been fully sequenced. In this study we developed and applied a genotype IV-specific tiling PCR enrichment approach recovering 52 CCHFV genome segment sequences from clinical and Hyalomma tick samples collected between 2017–2023. Most sequences belonged to the Asia-2 genotype, but one virus exhibited an Asia-1 S segment combined with Asia-2 M and L segments, representing the first evidence of such viral reassortment event in Tajikistan.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Infection Biology, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, United Kingdom.
- Public Health Microbiology Directorate, UK Health Security Agency, Salisbury, United Kingdom.
- Virology Laboratory, Tajik Research Institute of Preventative Medicine, Dushanbe, Tajikistan.
- Department of Applied Mathematics, University of Leeds, Leeds, United Kingdom.
- Theoretical Biology and Biophysics Group, Theoretical Division, Los Alamos National Laboratory, Los Alamos, New Mexico, United States of America.
- Genomic Surveillance Unit, Wellcome Sanger Institute, Hinxton, United Kingdom.
ORCID-Profile: Jake D'Addiego
Förderung
- NIAID NIH HHS
- Biotechnology and Biological Sciences Research Council
- National Institute of Allergy and Infectious Diseases
Zitieren
APA
D'Addiego, J., Tishkova, F., Mullojonova, M., Dzhuraeva, V., Lythe, G., Dent, S., Molina-París, C., Leitner, T., & Hewson, R. (2026). Genomic characterisation of Crimean-Congo haemorrhagic fever virus (CCHFV) in Tajikistan identifies a novel reassortant virus. PLOS Neglected Tropical Diseases, 20(4), e0014204. https://doi.org/10.1371/journal.pntd.0014204
Vancouver
D'Addiego J, Tishkova F, Mullojonova M, Dzhuraeva V, Lythe G, Dent S, et al. Genomic characterisation of Crimean-Congo haemorrhagic fever virus (CCHFV) in Tajikistan identifies a novel reassortant virus. PLOS Neglected Tropical Diseases. 2026;20(4):e0014204. doi:10.1371/journal.pntd.0014204
BibTeX
@article{DAddiego2026,
author = {D'Addiego, Jake and Tishkova, Farida and Mullojonova, Manija and Dzhuraeva, Viktoriya and Lythe, Grant and Dent, Stuart and Molina-París, Carmen and Leitner, Thomas and Hewson, Roger},
title = {Genomic characterisation of Crimean-Congo haemorrhagic fever virus (CCHFV) in Tajikistan identifies a novel reassortant virus},
journal = {PLOS Neglected Tropical Diseases},
year = {2026},
volume = {20},
number = {4},
pages = {e0014204},
doi = {10.1371/journal.pntd.0014204}
}
EUVIMED